Current Trends in Oncology: Prevention and Diagnostics

This scientific session will explore the latest advances in cancer prevention, early detection, and diagnostic innovation. The programme will bring together researchers, clinicians, and public health experts to discuss emerging technologies and evidence-based approaches that are reshaping oncology, from personalized risk assessment and genetic testing to artificial intelligence, liquid biopsy, and the translation of novel discoveries into routine clinical practice. The session aims to highlight strategies that improve early cancer detection, enable precision prevention, and ultimately reduce the burden of cancer on individuals and healthcare systems.

Scientific Committee

• Mirjam Blattner-Johnson (Latvia / Germany)
  Tenured professor, RSU / Hopp Children's Cancer Center Heidelberg
• Prof. Jānis Gardovskis (Latvia)
  Dr. habil. med., Rīga Stradiņš University
• Prof. Edvīns Miklaševičs (Latvia)
  Dr. biol., Rīga Stradiņš University
• Prof. Zanda Daneberga (Latvia)
  Dr. med., Rīga Stradiņš University
• Assoc. Prof. Arvīds Irmejs (Latvia)
  Rīga Stradiņš University
• Prof. Jacek Gronwald (Poland)
  MD, PhD, DSc, Pomeranian Medical University

Main topics

• Screening and Prevention in Oncology
• Non-invasive Biomarkers and Liquid Biopsy
• AI and Digital Technologies in Oncology
• Hereditary Cancers and Cancer Genetics
• Translation of Innovations in Oncology

Keynote Speakers

Prof. Toni Seppälä

Tampere University, Finland

Prof. Olli Carpén

University of Helsinki, Finland